Gennaro Giustino, MD Profile Banner
Gennaro Giustino, MD Profile
Gennaro Giustino, MD

@g_giustinoMD

Followers
2,484
Following
1,202
Media
147
Statuses
904

🇮🇹 Structural Interventional Cardiologist

New York, USA
Joined January 2011
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@g_giustinoMD
Gennaro Giustino, MD
5 years
So humbled to see the "Giustino Criteria" summarized in this great editorial by @DFCapodanno in @EuroInterventio evaluating antithrombotic strategies after Complex PCI. Continuously evolving field. More research is needed! @Drroxmehran @GreggWStone @MountSinaiHeart
Tweet media one
11
49
197
@g_giustinoMD
Gennaro Giustino, MD
2 years
Happy Birthday to Dr Fuster!!! Thank you for leading us by example with your hard work and dedication to patient care, mentorship and teaching. @SinaiCards @MountSinaiHeart @ACCinTouch
Tweet media one
8
36
562
@g_giustinoMD
Gennaro Giustino, MD
2 years
Just published in @JACCJournals our state-of-the art review on the pathophysiology, diagnosis and management of LV thrombus following acute MI. Led by @SinaiCards fellow @acamajmd ! @MountSinaiHeart
Tweet media one
Tweet media two
Tweet media three
Tweet media four
6
81
340
@g_giustinoMD
Gennaro Giustino, MD
3 years
When your papers get mentioned by Dr Fuster during morning conference on the CV effects of COVID-19 💫 @SinaiCards @ACCinTouch @JACCJournals @MountSinaiHeart
Tweet media one
7
11
180
@g_giustinoMD
Gennaro Giustino, MD
2 years
Just out in @JACCJournals our SOA on the incidence, mechanisms, characterization and treatment of in-stent restenosis (ISR). Massive effort summarizing decades of data and we propose treatment algorithm based on the underlying substrate of ISR.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
57
173
@g_giustinoMD
Gennaro Giustino, MD
1 year
Last PCI at @MountSinaiHeart and end of an era! I am forever grateful to my Mount Sinai family but very excited to be joining the great team at @HenryFordHealth for Structural Heart Disease fellowship!! Goodbye NYC, I’ll be back
Tweet media one
19
3
174
@g_giustinoMD
Gennaro Giustino, MD
4 years
Our 3-part state-of-the-art review on the cardiovascular and metabolic effects of Covid-19 in press today in @JACCJournals . Honored to have contributed to this multi-disciplinary effort led by @spinneymd and Dr Fuster at @MountSinaiHeart .
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
50
163
@g_giustinoMD
Gennaro Giustino, MD
2 years
Just published in @JACCJournals our manuscript on the antithrombotic management of patients requiring pLVAD support. Great international collaboration led by @CVandenbriele @alaide_chief . Lots of practical recs on monitoring / prevention and tx of complications. Must read.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
39
144
@g_giustinoMD
Gennaro Giustino, MD
2 years
Got a nice present in the mail yesterday… Happy to have contributed to the new edition of The Heart @ACCinTouch @SinaiCards @MountSinaiHeart @spinneymd @MHEducation
Tweet media one
Tweet media two
Tweet media three
6
13
137
@g_giustinoMD
Gennaro Giustino, MD
4 months
2nd commercial TTVR Evoque case performed <45 min (50s cumulative experience at @HenryFordHealth ). No leak, no gradient, no AVB. D/c POD1. Great team and the best SHD imager @DeeDeeWangMD ! The TAVR of tricuspid @Edwards_TAVR @EdwardsLifesci @PedroMDMSc @BillONeillMD
Tweet media one
Tweet media two
Tweet media three
Tweet media four
7
12
117
@g_giustinoMD
Gennaro Giustino, MD
4 years
Published today in @JACCJournals our study evaluating the echocardiographic abnormalities of hospitalized patients with Covid-19 and myocardial injury. Incredible collaboration in the middle of the pandemic between NYC and Milan hospitals. @GGStefanini
Tweet media one
3
21
101
@g_giustinoMD
Gennaro Giustino, MD
7 months
Pts with severe MAC and MS are often not surgical candidates or have other transcatheter options. Here we report the largest series to date of IVL-facilitated mitral valvuloplasty for severe MAC/MS. Feasible, safe and associated with ⬇️ in gradients.
Tweet media one
Tweet media two
4
15
97
@g_giustinoMD
Gennaro Giustino, MD
6 months
Critical AS/MS from prior surg valve presenting in cardiogenic shock. LAVA-ECMO stabilized pt (PAP from >100 to <40), renal function recovered. Now s/p simultaneous aortic ViV with pre- fracture and mitral ViV on ECMO. Iatrogenic ASD closed w Amplatzer. Decannulated at the end
Tweet media one
Tweet media two
Tweet media three
5
17
93
@g_giustinoMD
Gennaro Giustino, MD
3 years
Cardiology Fellowship application is open!! Come train at @MountSinaiHeart with world-renowned leaders in the field and the best group of fellows in the heart of Manhattan @SinaiCards @IcahnMountSinai
Tweet media one
2
12
93
@g_giustinoMD
Gennaro Giustino, MD
2 years
That day when your H-index surpasses your chronological age…
Tweet media one
9
0
90
@g_giustinoMD
Gennaro Giustino, MD
2 months
OSH transfer for cardiogenic shock, severe AS, 3-v CAD with left main, severe PAD. Stabilized with single access transcaval (TC) Impella CP + BAV via 18Fr DrySeal across cavo-aortic track. Snaring and venoarterial rail for TC done from left radial. @PedroMDMSc @HFHCardioFellow
Tweet media one
Tweet media two
Tweet media three
8
14
91
@g_giustinoMD
Gennaro Giustino, MD
4 years
This may be one of the most important 2nd analysis from the ISCHEMIA trial. 1) Spontaneous MI reduced with INV strategy, including PCI, CABG or no revasc; 2) Only spontaneous MI a/w increased all-cause mortality, irrespective of the definition. VERY important data. @ACCinTouch
Tweet media one
Tweet media two
2
34
89
@g_giustinoMD
Gennaro Giustino, MD
5 years
So honored to have authored this @CircAHA paper on the highlights of the last TCT 2019, including a summary of all the RCTs that were presented. TCT is an incredible learning opportunity! See you all next year in Miami!! @TCTConference @crfheart @GreggWStone @TCTMD
Tweet media one
4
4
86
@g_giustinoMD
Gennaro Giustino, MD
14 days
Heading towards the end of SHD fellowship, just another week at Henry Ford….. : - 4 transjugular TTVR evoque (all successful) - 1 transjugular PVL closure of an Evoque (no residual PVL) - 2 JenaValve for AI of which one in a quadricuspid aortic valve in a pt with an LVAD -
Tweet media one
Tweet media two
Tweet media three
Tweet media four
9
5
85
@g_giustinoMD
Gennaro Giustino, MD
6 months
Interesting analysis describing the patterns of chimney stenting morphology for coronary protection during TAVR; most are severely deformed with potentially very complex re-access. Leaflet modification techniques may be preferred to maintain coronary flow in high-risk anatomies
Tweet media one
3
18
80
@g_giustinoMD
Gennaro Giustino, MD
2 years
1-Just published in @JACCJournals our analysis from the COAPT trial evaluating the effects of TEER with MitraClip vs GDMT alone on fatal- and non-fatal hospitalizations, their independent predictors and their relationship with mortality @GreggWStone
Tweet media one
2
7
77
@g_giustinoMD
Gennaro Giustino, MD
4 years
Published this week in @JACCJournals our analysis from the COAPT trial evaluating the effect of MitraClip vs. GDMT in pts with HF and sev SMR demonstrating consistent benefits across NYHA II, III and IVa. Can MitraClip be beneficial in minimally symptomatic pts with sev SMR?
Tweet media one
Tweet media two
3
26
77
@g_giustinoMD
Gennaro Giustino, MD
4 months
In press in @EuroInterventio our experience using ad-hoc TC access for VA-ECMO cannulation. Feasible and safe. When used in a LAVA-ECMO configuration, allows for circulatory support with active LV unloading using only peripheral venous access. More to come.
Tweet media one
Tweet media two
Tweet media three
2
14
74
@g_giustinoMD
Gennaro Giustino, MD
4 years
1) PARTNER 3 4DCT Study reporting the incidence of subclinical valve thrombosis after TAVR and SAVR finally published in @JACCJournals . Honored to have contributed with this Editorial together with @PhilGenereuxMD .
Tweet media one
1
13
75
@g_giustinoMD
Gennaro Giustino, MD
7 months
“Minimalistic” alternative access for TAVR - fully perc left subclavian 26 mm S3 with bilateral radial access; 7Fr ipsilateral radial for dry sheath exchange and closure using hemostatic balloon (IVUS sized); 2 pre-deployed perclose; pace over Confida wire; conscious sedation.
1
6
73
@g_giustinoMD
Gennaro Giustino, MD
8 months
Good saturday night case - young pt, aortic valve endocarditis refractory cardiogenic shock. Transcaval ICE-guided LAVA-ECMO without pre- contrast CT. Full cardiocirculatory support with LV venting w only peripheral venous access. Thanks to @PedroMDMSc @HFHCardioFellow
4
9
70
@g_giustinoMD
Gennaro Giustino, MD
4 years
Just Published in @JACCJournals our manuscript reporting the incidence, characteristics and impact of patients with features of Takotsubo Cardiomyopathy on TTE and myocardial injury in the setting of Covid-19. Interesting, all cases were males!
Tweet media one
5
11
69
@g_giustinoMD
Gennaro Giustino, MD
3 years
Great honor. Thankful to my cofellows and the @MountSinaiHeart faculty to have chosen me.
@SinaiCards
Mount Sinai Cardiology Fellowship
3 years
We are extremely proud to announce our chief cardiology fellows for the 2021 - 2022 academic year The fantastic @g_giustinoMD and @waqasmalick5 Congratulations!!
Tweet media one
0
1
49
8
0
69
@g_giustinoMD
Gennaro Giustino, MD
3 years
One of my favorites of @TCTConference is definitely the Linnemier awards and I am so proud that this year my dear friend @VPanoulas was one of the finalist!! Long time has passed since our time at @SRCathLab !! @alaide_chief @MMontorfanoOSR @azeemlatib
Tweet media one
1
4
69
@g_giustinoMD
Gennaro Giustino, MD
1 year
Honored to see our manuscript on Coronary In-Stent Restenosis among the top 2022 papers in interventional cardiology published in the @JACCJournals Pumped to try to make it in this list also in 2023!!
Tweet media one
Tweet media two
0
6
68
@g_giustinoMD
Gennaro Giustino, MD
2 years
Just presented at #EuroPCR2022 @PCRonline and published in @JACCJournals a large patient-level pooled analysis evaluating the effect of a staging classification for AS based on the extent of cardiac damage, originally described by @PhilGenereuxMD et al.
5
12
63
@g_giustinoMD
Gennaro Giustino, MD
3 years
Just published in @EuroInterventio the TWILIGHT-STENT analysis demonstrating consistent efficacy and safety of a strategy of ticagrelor monotherapy vs DAPT; no signals for increased risk of ischemic events across DES platforms. @SinaiCards
Tweet media one
1
14
62
@g_giustinoMD
Gennaro Giustino, MD
3 years
A legend, my lifelong mentors and me @Drroxmehran @georgedangas @AlainCribier NY Transcatheter Valves @NytvL
Tweet media one
1
3
60
@g_giustinoMD
Gennaro Giustino, MD
4 years
The talented one in the family SO PROUD OF YOU @LorenzoGiustino Giustino defeats Moutet in more than 6-h match 0/6 7/6 7/6 2/6 18/16 2nd longest match in the history of @rolandgarros
Tweet media one
2
2
59
@g_giustinoMD
Gennaro Giustino, MD
3 years
So proud of my dear friend @drbirgitvogel , brilliant Austrian cardiologist who CRUSHED this ACC 2021 with 1 LBCT, 1 @JAMACardio and this massive @TheLancet 1st-auth publication. Years of hard work paying off. Congratulations! @MountSinaiNYC @MountSinaiHeart @ACCinTouch
Tweet media one
4
7
58
@g_giustinoMD
Gennaro Giustino, MD
4 years
Brilliant study published in @JAMACardio by @SIC_CARDIOLOGIA president @IndolfiCiro team supporting agreement between a commercially available multichannel smartwatch ECG vs. a conventional 12-lead ECG for the detection of ST-segment changes in pts with ACS. Congrats!
Tweet media one
Tweet media two
2
20
57
@g_giustinoMD
Gennaro Giustino, MD
2 years
Just presented at #EuroPCR2022 our analysis from the GALILEO trial evaluating the effect of thromboembolic / bleeding events on mortality after a successful uncomplicated TAVR in a predominantly int risk pt population (age ~80 yrs / STS ~4) w/o need for OAC @PCRonline
Tweet media one
Tweet media two
2
2
55
@g_giustinoMD
Gennaro Giustino, MD
4 years
Our editorial on Left Main revascularization strategies in patients with CKD. Extending from a heart-team to a heart-kidney-team approach, incorporating clinical considerations unique to CKD patients. @EuroInterventio @GreggWStone @MountSinaiHeart
Tweet media one
0
15
54
@g_giustinoMD
Gennaro Giustino, MD
8 months
From early transcaval (TC) adoption to re-do TC access for failed S3 in pt with unsuitable peripheral arteries. TAV-in-TAV with re-do TC access (L2 level, above previous ADO device). Successful closure with second ADO. @PedroMDMSc @HFHCardioFellow
Tweet media one
Tweet media two
Tweet media three
Tweet media four
4
12
52
@g_giustinoMD
Gennaro Giustino, MD
3 years
Honored to have been nominated and featured this week at the Mount Sinai Hospital for educational efforts in cardiovascular medicine. More than any other achievement, our legacy of mentors, mentees and colleagues it's our most important asset. @MountSinaiHeart @SinaiCards
Tweet media one
4
2
53
@g_giustinoMD
Gennaro Giustino, MD
4 years
I have been doing COVID-ICU shifts around the clock and I will expand on this bcs I have never been more PROUD of our Hospital. 1) Tremendous collaborative effort across multiple specialties. 2) Support and responsiveness from the Leadership has been EXCELLENT @GreggWStone
@GreggWStone
Gregg W. Stone MD
4 years
At the Mount Sinai Hospital system, we’ve been running ~2000 COVID-19 in-pts per day, with ~500 in ICUs. Finally starting to see a downturn in these numbers. More than 2800 patients have been discharged. Amazing effort by everyone on the front line as well as hospital leadership.
16
59
364
3
2
51
@g_giustinoMD
Gennaro Giustino, MD
6 years
Just published in JACC a prespecified analysis from the EXCEL trial on PCI vs. CABG for LM disease in patients with CKD! PCI associated with lower risk of acute renal failure and new req for HD at 30 days. No sig differences at 3 yrs for death/stroke/MI between revasc strategies
Tweet media one
Tweet media two
4
21
50
@g_giustinoMD
Gennaro Giustino, MD
5 years
If at your PM panel discussion on management of Mitral Regurgitation you have Dr Fuster, Dr Stone, Dr Bonow, Dr Adams sitting together among other leaders, you are probably at the right place; Spectacular!!! @MountSinaiHeart @JACCJournals @ACCinTouch @GreggWStone @waqasmalick5
Tweet media one
0
3
49
@g_giustinoMD
Gennaro Giustino, MD
4 years
Covid ICU night shift xxxxx time in a row. Face challenges w strenght and excitement. It is a privilege to be serving and helping sick patients in OUR amazing city. We are lucky to do what we do. Go👋💪💪 #nytough @MountSinaiNYC
Tweet media one
1
3
48
@g_giustinoMD
Gennaro Giustino, MD
4 years
Honored to present a Late Breaking Clinical Science from the COAPT trial at the first #TVTConnect , evaluating the effects of MitraClip in pts with 2nd MR and HF across the spectrum of NYHA functional class. @crfheart @GreggWStone @MountSinaiHeart
@crfheart
Cardiovascular Research Foundation
4 years
Tweet media one
1
6
10
0
4
48
@g_giustinoMD
Gennaro Giustino, MD
8 months
FORZA ITALIA 💪🇮🇹
@alaide_chief
chief
8 months
Tweet media one
7
20
83
0
4
47
@g_giustinoMD
Gennaro Giustino, MD
3 years
Outstanding journal club on FAME-3 presented by @rowpower with @GreggWStone , @georgedangas , Dr Fuster. Issues with selection of NI margin, relative vs absolute diff, safety endpoints, MI definition. Do we need to shift from an ischemia-based to an anatomy-based approach for PCI?
Tweet media one
3
3
45
@g_giustinoMD
Gennaro Giustino, MD
3 months
Technique, effects, pittfals and use of proximal optimization technique during bifurcation stenting @MountSinaiHeart @JACCJournals
Tweet media one
0
13
44
@g_giustinoMD
Gennaro Giustino, MD
4 years
Welcome to ComplicAid a new digital learning tool from @MountSinaiHeart CathLab led by Dr Kini, Dr Sharma and Dr Johal. Great learning source for FITs. @MountSinaiHeart Cath Lab leading the way in digital education in IC. Have them in your phone!
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
8
45
@g_giustinoMD
Gennaro Giustino, MD
4 years
Our letter to @NEJM on the ISCHEMIA trial - important to dissect the early hazard from the late benefit of an invasive strategy. Long-term follow-up of ISCHEMIA will be critical to inform the management of pts with stable CAD.
Tweet media one
2
9
44
@g_giustinoMD
Gennaro Giustino, MD
2 years
Describing what @georgedangas has done for my career and to the one of so many others goes beyond a post on twitter. A genuine and inspirational mentor in and outside of the lab, research and life. I am so proud. @SinaiCards @MountSinaiHeart @ACCinTouch @crfheart @TCTMD #ACC22
@crfheart
Cardiovascular Research Foundation
2 years
CRF congratulates our esteemed @TCTConference Course Director, @georgedangas on being designated a Master of the American College of Cardiology! We salute your leadership in and dedication to education and clinical practice. #ACC22 @ACCinTouch
Tweet media one
4
12
85
1
1
42
@g_giustinoMD
Gennaro Giustino, MD
4 years
Stay strong and keep fighting 🇮🇹💪
Tweet media one
0
5
42
@g_giustinoMD
Gennaro Giustino, MD
4 years
9/11 - Never forget. New York City will stand up again. Always has and always will.
Tweet media one
0
2
42
@g_giustinoMD
Gennaro Giustino, MD
3 years
Well... @waqasmalick5 , @MichaelHadleyMD and I just had the honor of having a 1-1 conversation with the legendary Dr Braunwald. He shared his vision and future areas of research and clinical practice. Inspirational. @SinaiCards @MountSinaiHeart @ACCinTouch
Tweet media one
0
1
40
@g_giustinoMD
Gennaro Giustino, MD
5 years
My wholehearted congratulations to the TWILIGHT investigators and team led by @Drroxmehran and @ubcardio for completing this highly impactful and rigorously designed study.. such an incredible journey and more to come! @TCTMD @crfheart @TCTConference @MountSinaiHeart
Tweet media one
Tweet media two
1
4
41
@g_giustinoMD
Gennaro Giustino, MD
5 years
1/ GALILEO just published in @NEJM , has been such an honor to have been involved in this landmark RCT testing the anticoagulation hypothesis in Transcatheter bioprosthetic valves
Tweet media one
Tweet media two
2
2
38
@g_giustinoMD
Gennaro Giustino, MD
6 months
Great review from the @SRValveCenter discussing the issues around valve crossing in bioprosthetic valve failure. Must read. I think if struggling too much or unsure, go transeptal! @alaide_chief @MMontorfanoOSR @PedroMDMSc
Tweet media one
0
10
39
@g_giustinoMD
Gennaro Giustino, MD
3 years
Brother @LAzzaliniMD was back in in town today!!! @VCU is so lucky to have you
Tweet media one
2
2
36
@g_giustinoMD
Gennaro Giustino, MD
4 years
TVT Late-Breaking Clinical Science Happening now! Connect! Link: #TVTConnect #TVT2020 @crfheart @mirvatalasnag
Tweet media one
0
7
37
@g_giustinoMD
Gennaro Giustino, MD
5 years
When deciding DAPT duration post-PCI - high bleeding risk (HBR) status should take priority over ischemic risk. Benefit with long-term DAPT in Complex PCI observed only if HBR features were NOT present. Strong work by @Costa_F_8 !!
Tweet media one
1
12
36
@g_giustinoMD
Gennaro Giustino, MD
4 years
Published this week in @JACCJournals our study evaluating the impact of repeat revasc after PCI or CABG for Left Main Disease. Thank you @michaelTCTMD @TCTMD for covering this, nicely summarizes the key findings.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
8
34
@g_giustinoMD
Gennaro Giustino, MD
5 years
It was an honor to be invited to contribute with an editorial comment for @JACCJournals but even more important to do it with my friend and colleague @Costa_F_8 .
Tweet media one
Tweet media two
0
7
32
@g_giustinoMD
Gennaro Giustino, MD
3 years
TVT is live! Dr @GilbertTangMD from @MountSinaiHeart presenting the impact of timing of MV surgery on outcomes in the CUTTING-EDGE Registry @crfheart @crfshj @GreggWStone
Tweet media one
1
5
32
@g_giustinoMD
Gennaro Giustino, MD
4 months
Redo Transcaval Access and Closure for Redo Transcatheter Aortic Valve Replacement | JACC: Cardiovascular Interventions @PedroMDMSc @DeeDeeWangMD @BillONeillMD @TiberioFrisoli @HenryFordHealth @HFHCardioFellow
Tweet media one
Tweet media two
0
3
31
@g_giustinoMD
Gennaro Giustino, MD
7 months
Optimization of valve expansion for TMVR. Degenerated 27mm Magna w sev stenosis, pre-fractured with 28mm 🎈. 29mm S3 implanted, further post-dilated on atrial side to improve expansion. No post gradient, no leak. Paced OTW. Sentinel captured calcific debries. CT neo-LVOT 321.
1
5
29
@g_giustinoMD
Gennaro Giustino, MD
4 months
Coiling of enlarging basal LV pseudoaneurysm. Pt not surgical candidate. Pseudo wired transeptally via 0.035 Omniflush catheter within an Agilis. 32 penumbra coils delivered via 0.025 Lantern microcatheter. @HFHCardioFellow
Tweet media one
Tweet media two
0
3
30
@g_giustinoMD
Gennaro Giustino, MD
9 months
TCT-263 Percutaneous Coronary Intervention Risk Stratification: SYNTAX Score vs. Complex PCI Score Oral presentation on Wednesday 10/25. Full paper coming... @MountSinaiHeart @MountSinaiNYC @SinaiCards @Drroxmehran @DoctorKini
0
1
29
@g_giustinoMD
Gennaro Giustino, MD
5 years
@waqasmalick5
Waqas Malick MD
5 years
Awesome evening hanging out with Dr. Fuster, Dr. Stone, Dr. Pinney and the best fellow class at Mount Sinai Heart @GreggWStone @spinneymd @g_giustinoMD @MountSinaiHeart @HashemiHelen @chizhangmd
Tweet media one
0
2
12
1
1
29
@g_giustinoMD
Gennaro Giustino, MD
4 months
Young pt w NIC in CS s/p r Ax 5.5 Impella waiting for OHT, having severe hemolysis. Switched to LAVA-ECMO to provide support and LV unloading. Art cannula inserted and sewed within the Ax conduit avoiding 2nd art access and lower ext ischemia. LAVA cannula from RFV @PedroMDMSc
Tweet media one
Tweet media two
Tweet media three
0
2
22
@g_giustinoMD
Gennaro Giustino, MD
4 years
My thoughts are to my colleagues in Italy on the frontline. We are a country of talented, passionate and genuine people. We will make it. Forza!!🇮🇹💪❤️
@ValaAfshar
Vala Afshar
4 years
During Italy's quarantine, tenor and opera singer Maurizio Marchini wanted to give people hope and joy. So he went to his balcony and serenaded the entire town of Florence. The song is "Nobody Shall Sleep." and ends with “with the dawn, I will win.”
194
3K
9K
0
0
28
@g_giustinoMD
Gennaro Giustino, MD
5 years
When your thursday morning lecture is Dr Fuster discussing the future in cardiovascular research 💫 @MountSinaiNYC @MountSinaiHeart @ACCinTouch @JACCJournals
Tweet media one
0
4
25
@g_giustinoMD
Gennaro Giustino, MD
1 year
Just released and available for download on AppStore our new app called MCSaid! An educational and decision-making tool to guide the use of MCS for patients with cardiogenic shock. Thankful to @DoctorKini @MountSinaiHeart @SinaiCards @Abiomed @DrSethdb
Tweet media one
Tweet media two
1
4
27
@g_giustinoMD
Gennaro Giustino, MD
3 years
Outstanding state-of-the-art review on management strategies of CVD in pts with CKD/ESRD from @MountSinaiHeart team led by star cardiology fellow @SWBienMD and the brilliant incoming fellow @AshtonLaiMDPhD . People like you make our program proud!!
Tweet media one
Tweet media two
Tweet media three
0
4
27
@g_giustinoMD
Gennaro Giustino, MD
3 years
This is an incredible opportunity - Outstanding cardiovascular clinical training coupled by world-class reaserch training at @MountSinaiHeart @SinaiCards @GreggWStone @ACCinTouch
@SinaiCards
Mount Sinai Cardiology Fellowship
3 years
@MichaelHadleyMD and @g_giustinoMD present the research curriculum overview for @SinaiCards fellows - world class, small group research lectures with @GreggWStone @FusterValentin @Stuartpocock2 - formal STATA workshops - statistical/IRB support - formal mentorship pairing
Tweet media one
Tweet media two
Tweet media three
0
2
20
0
1
26
@g_giustinoMD
Gennaro Giustino, MD
5 years
Happy Diwali!!! from @MountSinaiHeart
Tweet media one
0
0
27
@g_giustinoMD
Gennaro Giustino, MD
3 years
Evening recording for upcoming virtual @AHAMeetings . Session on STEMI: great discussion on mvCAD, Shock/MCS, MINOCA and more. Looking forward to AHA ‘21! @CMichaelGibson @nadia_sutton @VijayKunadian @HollandTamis @SinaiCards @MountSinaiHeart
Tweet media one
1
2
27
@g_giustinoMD
Gennaro Giustino, MD
6 years
Just found this on @NEJM Thank god Italy is not playing this year😂😂😂 @Costa_F_8 @SABOURETCardio
Tweet media one
2
11
27
@g_giustinoMD
Gennaro Giustino, MD
4 years
@PCRonline
PCRonline 🫀
4 years
Mortality after repeat revascularization following PCI or CABG for left main disease. Read this #EAPCI /PCR Journal Club review ✍️🏼 of a sub-analysis of the EXCEL trial by @mirvatalasnag & @drptca (illustration credit @JACCJournals )
Tweet media one
0
18
37
1
3
26
@g_giustinoMD
Gennaro Giustino, MD
6 years
Great editorial on the past, current state and future perspective of CTO-PCI @JACCJournals @GreggWStone
Tweet media one
1
8
22
@g_giustinoMD
Gennaro Giustino, MD
4 years
Just published in @CircAHA our series at @MountSinaiHeart of young male pts presenting with Covid-19, hyperinflammatory status and shock. Cases appeared to be responsive to tx with steroids, A/C and supportive care. @EstefaniaOS @dranulala @spinneymd
Tweet media one
0
2
24
@g_giustinoMD
Gennaro Giustino, MD
5 years
Spectacular morning conference on Atrial Fibrillation this morning at @MountSinaiHeart with Dr Halperin, Fuster, Liao amd Reddy @ACCinTouch @JACCJournals
Tweet media one
1
3
23
@g_giustinoMD
Gennaro Giustino, MD
3 years
Thank you Dr Stone for all your mentorship and guidance. Full paper coming!! @MountSinaiHeart @SinaiCards
@GreggWStone
Gregg W. Stone MD
3 years
Late breaking science from COAPT presented by Gennaro Giustino at TCT2021. Rehospitalizations, esp HF- and CV-related, were associated with increased death. MitraClip c/w GDMT reduced fatal & non-fatal hosps but did not modify the association between hosps and subsequent death.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
8
40
0
2
22
@g_giustinoMD
Gennaro Giustino, MD
2 years
Just published in @JCardFail our analysis from the STICH trial where we used multiple methods to account for tx crossover. Significant and sustained survival benefit among surgically-eligible pts with severe ischemic cardiomyopathy who received CABG vs MT alone.
@JCardFail
Journal of Cardiac Failure
2 years
🔥Latest JCF Ignite! - New STICH Analysis "Re-analysis of the effect of CABG surgery in patients with left ventricular dysfunction" By Drs. Bart Ferket, Donna Mancini et al @emiliabagiella @g_giustinoMD @MountSinaiNYC 🧵 @robmentz @dranulala @HFSA 👉🏽
Tweet media one
Tweet media two
1
20
35
0
6
21
@g_giustinoMD
Gennaro Giustino, MD
3 years
Proud of The Mount Sinai Hospital ranked Top 10 hospital in the Country by Newsweek, #1 in New York City and #5 for Cardiovascular Medicine in the World. Great job from our leadership to always strive to improve clinical care, patient experience and quality of our training
Tweet media one
1
2
21
@g_giustinoMD
Gennaro Giustino, MD
4 years
Spectacular piece from our Echo lab director Lori Croft. She was a true hero during the pandemic. Always on the front line, helping others and performing TTEs on critically-ill pts with Covid. We are lucky to be trained by her at @MountSinaiHeart
Tweet media one
0
2
21
@g_giustinoMD
Gennaro Giustino, MD
3 years
Another cardiology fellowship recruitment season has been completed. Very competitive year. We matched a stellar group of residents (3 MGH/Harvard, 1 Yale chief, 1 Mount Sinai chief, 1 Mount Sinai). Welcome to the @SinaiCards family. Looking forward to working with you all!
@SinaiCards
Mount Sinai Cardiology Fellowship
3 years
We are thrilled to welcome this phenomenal group of future cardiology fellows to @MountSinaiHeart ! Welcome to the @SinaiCards Family! 🎉🎉 @Adam_Russak , @ChrisMarnell2 , @Ksharma9000 , JorgeZamalloa, AidanMilner, KyleNelson @MountSinaiNYC @IcahnMountSinai
Tweet media one
4
4
68
0
0
20
@g_giustinoMD
Gennaro Giustino, MD
4 years
Congratulations to our leader and mentor Dr Valentin Fuster, one of the most prominent cardiologists in the world and living legend in cardiovascular medicine!! @JACCJournals @MountSinaiHeart @SinaiCards
0
0
21
@g_giustinoMD
Gennaro Giustino, MD
4 years
This is just incredible. I am SO SO SO SO proud to have, even in a small part, contributed to this. Stay strong NYC @MountSinaiNYC @MountSinaiHeart @DOMSinaiNYC
@MountSinaiNYC
Mount Sinai Health System
4 years
As of April 24, a total of 3,929 #COVID19 patients system-wide have returned home. #MountSinaiStrong
0
19
51
0
2
20
@g_giustinoMD
Gennaro Giustino, MD
6 months
TEE-guided Angiovac extraction of a TV endocarditis obstructive mass. 26 Fr Dryseal in RIJ for the Angiovac cannula. 17 Fr ECMO cannula in RFV for VV-ECMO circuit for blood recirculation. Both pre-closed x2. @HFHCardioFellow @PedroMDMSc
1
0
19
@g_giustinoMD
Gennaro Giustino, MD
6 years
Writing a paper on severe ischemic MR. Just found this great review from @JudyHungMD on #echofirst assessment of ischemic MR. Highly recommended to all FITs!
Tweet media one
0
6
19
@g_giustinoMD
Gennaro Giustino, MD
2 years
I started working on the DELTA-2 registry when I was still a medical student and I am so happy that after so many years we are still producing high quality research!! Thank you @alaide_chief for your mentorship
@alaide_chief
chief
2 years
Sex differences in outcomes in # #LM Revascularization @JAHA_AHA @FrnMoroniMD @ABeneduceMD @g_giustinoMD thanks to all coauthors
Tweet media one
1
5
36
0
2
20
@g_giustinoMD
Gennaro Giustino, MD
4 years
It would apply to so many
@AFawzyElsayed
Ahmed Fawzy
4 years
Do you agree with all 3 of these? 🤔
Tweet media one
6
9
56
0
2
20
@g_giustinoMD
Gennaro Giustino, MD
4 years
Congratulations to the incoming cardiology fellows class at The Mount Sinai Hospital. All coming from outstanding residency programs. Looking forward to work with you! @MountSinaiHeart @SinaiCards
@SinaiCards
Mount Sinai Cardiology Fellowship
4 years
It is our pleasure to announce the fantastic Cardiovascular Disease Fellowship Class of 2021! @SinaiCards @MountSinaiHeart @IcahnMountSinai
Tweet media one
3
3
39
0
2
19
@g_giustinoMD
Gennaro Giustino, MD
4 years
Very important investigator-sponsored trial led by @MountSinaiHeart . We need high-quality RCT evidence to define the role of anticoagulation in hospitalized patients with Covid-19.
@GreggWStone
Gregg W. Stone MD
4 years
Thrombosis is a major contributor to poor outcomes in COVID. We’re randomizing 3600 hosp’d but not intubated COVID-19 pts to diff anticoagulation regimens. Investigator-sponsored study, Valentin Fuster PI. If interested email Gregg.Stone @mountsinai .org and Michael.Farkouh @uhn .ca.
Tweet media one
3
60
208
0
4
19
@g_giustinoMD
Gennaro Giustino, MD
5 years
I find what is happening at @EACTS very sad. False and inappropriate accusations to major RCTs leaders, and unbalanced interpretation of the data. These things do not happen at IC or gen cardiology meetings. This is harmful for the cardiovascular community and for patient care
4
4
18
@g_giustinoMD
Gennaro Giustino, MD
3 years
Honored to be part of this distinguished group of authors. Here we provide guidance on the optimal antithrombotic tx after coronary bifurcation stenting. Great collaboration between Europe, Asia and North America led by @MZimarino . @SinaiCards @MountSinaiHeart @EuroInterventio
@DFCapodanno
Davide Capodanno
3 years
A strategy algorithm proposal from the European Bifurcation Club on the duration of dual antiplatelet therapy after percutaneous coronary intervention of bifurcation lesions in patients who are not candidates to oral anticoagulation.
Tweet media one
5
59
140
1
3
18
@g_giustinoMD
Gennaro Giustino, MD
6 years
Do the benefits of more potent platelet inhibition extend beyond the coronary arteries? - Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation
Tweet media one
1
6
19